AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

METFORMIN BP

11 registrations across 3 African markets— 3 active

Markets with METFORMIN BP

Recent registrations

Brand / ProductMarketHolderStatusExpires
DIAFORMINE 850
TABLETS
🇷🇼RwandaBliss GVS Pharma LimitedactiveAug 2029
DIAFORMINE 500
TABLETS
🇷🇼RwandaBliss GVS Pharma LimitedactiveAug 2029
DIAFORMINE 1000
TABLETS
🇷🇼RwandaBliss GVS Pharma LimitedactiveAug 2029
METFORMIN 500MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2023
GLUMIN 500 TABLETS
TABLETS / 6X14
🇳🇬NigeriaSEAGREEN PHARMA LTD 3expiredAug 2021
METOMIN-500 500MG TABLETS
TABLETS
🇲🇼MalawiexpiredJun 2015
METOF-500 500MG TABLETS
TABLETS
🇲🇼MalawiexpiredJun 2012
METFORMIN- 500MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2010
METFORMIN-850 850MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2010
METFORMIN 500MG FILM-COATED TABLET
FILM-COATED TABLET
🇲🇼MalawiexpiredJun 2008
METFORMIN 850MG FILM COATED TABLET
FILM COATED TABLET
🇲🇼MalawiexpiredJun 2008

METFORMIN BP in Africa — Regulatory Overview

METFORMIN BP is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Rwanda, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 3 (27%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.